This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Further Reading
General
Canalis E (1996) Mechanisms of glucocorticoid action in bone: implications to glucocorticoid induced osteoporosis. J Clinn Endocrinol Metab 81: 3441–3447.
Hahn TJ, Halstead LR, Bran DT (1981) Effects of short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man. J Clin Endocrinol Metab 52: 111–115.
Naganathan V, Jones G, Nash P, et al. (2000) Vertebral fracture risk with long term glucocorticoids: prevalence, relationship to age, bone density and glucocorticoid use. Arch Intern Med 160: 2917–2922.
Van Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C (2000) Use of oral glucocorticoids and risk of fractures. J Bone Miner Res 15: 993–1000.
Weinstein RS, Jilka RL, Parfitt AF, Manalagas SC (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. J Clin Invest 102: 274–282.
Clinical Trials
Adachi J, Bensen W, Bianchi F, et al. (1996) Vitamin D and calcium in the prevention of corticosteroid-induced osteoporosis: a three year follow up study. J Rheumatol 23: 995–1000.
Adachi JD, Bensen WG, Brown J, et al. (1997) Intermittent etidronate therapy to prevent glucocorticoid-induced osteoporosis. N Engl J Med 337: 382–387.
Boutsen Y, Jamart J, Esselinckx W, Stoffel M, Devogelaer PJ (1997) Primary prevention of glucocorticoid-induced osteoporosis with intermittent intravenous pam idronate: a randomized trial. Calcif Tissue Int 61: 266–271.
Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM (1996) Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low dose corticosteroids in patients with rheumatoid arthritis. Ann Intern Med 125: 961–968.
Chavassieux PM, Arlot ME, Roux JP, et al. (2000) Effects of alendronate on bone quality and remodeling in glucocorticoid-induced osteoporosis: a histomorphometric analysis of transiliac biopsies. J Bone Miner Res 15: 754–762.
Cohen S, Levy RM, Keller M, et al. (1999) Risedronate therapy prevents glucocorticoid-induced bone loss. Arthritis Rheum 42: 2309–2318.
Hall GM, Daniels M, Doyle DV, et al. (1994) The effect of hormone replacement therapy on bone mass in rheumatoid arthritis treated with and without steroids. Arthritis Rheum 37: 1499–1505.
Lane NE, Sanchez S, Modin GW, et al. (1998) Parathyroid hormone treatment can reverse glucocorticoid-induced osteoporosis. J Clin Invest 102: 1627–1633.
Montemurro L, Schiraldi G, Fraidi P, et al. (1991) Prevention of corticosteroid induced osteoporosis with salmon calcitonin in sarcoid patients. Calcif Tissue Int 49: 71–76.
Reginster JY, Kuntz D, Verdicht W, et al. (1999) Prophylactic use of alfacalcidol in glucocorticoid-induced osteoporosis. Osteoporos Int 9: 75–81.
Reid DM, Hughes RA, Laan RFJM, et al. (2000) Efficacy and safety of daily risedronate in the treatment of glucocorticoid induced osteoporosis in men and women: a randomised trial. J Bone Miner Res 15: 1006–1013.
Reid IR, Wattie DJ, Evans MC, Stapleton JP (1996) Testosterone therapy in glucocorticoid treated men. Arch Intern Med 156: 1173–1177.
Ringe JD, Coster A, Meng T, Schacht E, Umbach R (1999) Treatment of glucocorticoid-induced osteoporosis with alfacalcidol/calcium versus vitamin D/calcium. Calcif Tissue Int 65: 337–340.
Saag K, Emkey R, Schnitzler TJ, et al. (1998) Alendronate for the prevention and treatment of glucocorticoid induced osteoporosis. N Engl J Med 339: 292–299.
Sambrook PN, Birmingham J, Kelly PJ, et al. (1993) Prevention of corticosteroid osteoporosis: a comparison of calcium, calcitriol and calcitonin. N Engl J Med 328: 1747–1752.
Rights and permissions
Copyright information
© 2004 Springer-Verlag London
About this chapter
Cite this chapter
Sambrook, P.N. (2004). Corticosteroid Osteoporosis. In: Osteoporosis in Clinical Practice. Springer, London. https://doi.org/10.1007/978-0-85729-402-9_21
Download citation
DOI: https://doi.org/10.1007/978-0-85729-402-9_21
Publisher Name: Springer, London
Print ISBN: 978-1-85233-757-5
Online ISBN: 978-0-85729-402-9
eBook Packages: Springer Book Archive